During the past decade, Tergooiziekenhuizen conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 5 clinical trials were completed, i.e. on average, 14.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tergooiziekenhuizen" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 8 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Borstkanker Onderzoek Groep" with 3 trials sponsored, "Maastricht University Medical Center" with 3 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tergooiziekenhuizen" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 9 trials as a collaborator, "Borstkanker Onderzoek Groep" with 3 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator and "AO Research Fund" with 1 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "Tergooiziekenhuizen" are "Breast Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Colorectal Cancer" (3 trials), "Prostate Cancer" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Tergooiziekenhuizen" in a lesser frequency.

Most popular intervention types in "Tergooiziekenhuizen" are "Drug" (31 trials), "Other" (9 trials), "Procedure" (6 trials), "Biological" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tergooiziekenhuizen" are 47 trials for "All" genders, 7 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Tergooiziekenhuizen". undefined are not yet recruiting, 8 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Tergooiziekenhuizen, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Tergooiziekenhuizen, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 14 trials that are defined as “Not Applicable".